fda warning letters compounded semaglutide tirzepatide 2025 US sends 25 to telehealth companies over claims on weight-loss drugs FDA issues 30 warning letters

Unlike semaglutide, which targets one hormone pathway, tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two separate hormone systems involved in appetite regulation and metabolism

Ask your provider or telehealth service directly which pharmacy is compounding your medication, and check that pharmacy's licensing status through your state pharmacy board's website

This new research will complement a new American Heart Association scientific statement, published in Circulation , highlighting the importance of identifying and treating people at increased risk for heart failure before symptoms develop

Proper Liposome Technology Not all "liposomal" products are created equal

The plastic and rubber in syringes can sometimes interact with the peptide, and theres a higher risk of contamination and dosage inaccuracy over time

Tuna meal, which contains about 100 g of tuna, contains about 160% of the high nutritional value of vitamin B12